Institution
Halmstad University
Education•Halmstad, Sweden•
About: Halmstad University is a education organization based out in Halmstad, Sweden. It is known for research contribution in the topics: Health care & Context (language use). The organization has 924 authors who have published 2803 publications receiving 63392 citations.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In this article, the concept of 4th Generation District Heating (4GDH) was defined, including the relations to district cooling and the concepts of smart energy and smart thermal grids.
1,654 citations
••
TL;DR: Some of the VANET research challenges that still need to be addressed to enable the ubiquitous deployment and widespead adoption of scalable, reliable, robust, and secure VANet architectures, protocols, technologies, and services are outlined.
Abstract: Recent advances in hardware, software, and communication technologies are enabling the design and implementation of a whole range of different types of networks that are being deployed in various environments. One such network that has received a lot of interest in the last couple of years is the Vehicular Ad-Hoc Network (VANET). VANET has become an active area of research, standardization, and development because it has tremendous potential to improve vehicle and road safety, traffic efficiency, and convenience as well as comfort to both drivers and passengers. Recent research efforts have placed a strong emphasis on novel VANET design architectures and implementations. A lot of VANET research work have focused on specific areas including routing, broadcasting, Quality of Service (QoS), and security. We survey some of the recent research results in these areas. We present a review of wireless access standards for VANETs, and describe some of the recent VANET trials and deployments in the US, Japan, and the European Union. In addition, we also briefly present some of the simulators currently available to VANET researchers for VANET simulations and we assess their benefits and limitations. Finally, we outline some of the VANET research challenges that still need to be addressed to enable the ubiquitous deployment and widespead adoption of scalable, reliable, robust, and secure VANET architectures, protocols, technologies, and services.
1,132 citations
••
University of Paris1, Medical University of Vienna2, Leiden University3, Paris Descartes University4, University of Leeds5, Ruhr University Bochum6, Charité7, University College Dublin8, Halmstad University9, Katholieke Universiteit Leuven10, University of Münster11, University of Glasgow12, Charles University in Prague13, University of Erlangen-Nuremberg14, Ghent University Hospital15
TL;DR: These recommendations provide stakeholders with an updated consensus on the pharmacological treatment of PsA and strategies to reach optimal outcomes in PsA, based on a combination of evidence and expert opinion.
Abstract: Background Since the publication of the European League Against Rheumatism recommendations for the pharmacological treatment of psoriatic arthritis (PsA) in 2012, new evidence and new therapeutic agents have emerged. The objective was to update these recommendations. Methods A systematic literature review was performed regarding pharmacological treatment in PsA. Subsequently, recommendations were formulated based on the evidence and the expert opinion of the 34 Task Force members. Levels of evidence and strengths of recommendations were allocated. Results The updated recommendations comprise 5 overarching principles and 10 recommendations, covering pharmacological therapies for PsA from non-steroidal anti-inflammatory drugs (NSAIDs), to conventional synthetic (csDMARD) and biological (bDMARD) disease-modifying antirheumatic drugs, whatever their mode of action, taking articular and extra-articular manifestations of PsA into account, but focusing on musculoskeletal involvement. The overarching principles address the need for shared decision-making and treatment objectives. The recommendations address csDMARDs as an initial therapy after failure of NSAIDs and local therapy for active disease, followed, if necessary, by a bDMARD or a targeted synthetic DMARD (tsDMARD). The first bDMARD would usually be a tumour necrosis factor (TNF) inhibitor. bDMARDs targeting interleukin (IL)12/23 (ustekinumab) or IL-17 pathways (secukinumab) may be used in patients for whom TNF inhibitors are inappropriate and a tsDMARD such as a phosphodiesterase 4-inhibitor (apremilast) if bDMARDs are inappropriate. If the first bDMARD strategy fails, any other bDMARD or tsDMARD may be used. Conclusions These recommendations provide stakeholders with an updated consensus on the pharmacological treatment of PsA and strategies to reach optimal outcomes in PsA, based on a combination of evidence and expert opinion.
802 citations
••
TL;DR: In this article, six different strategies have been proposed for the European Union (EU) energy system in the European Commission's report, Energy Roadmap 2050, the objective for these strategies is to ide...
672 citations
••
TL;DR: The constant comparative method of grounded theory was first proposed by Glaser and Strauss as discussed by the authors, who were at the forefront of what can be called a "qua-qua...
Abstract: Approximately 40 years ago, Barney Glaser and Anselm Strauss and their joint research approach, the constant comparative method of grounded theory, were at the forefront of what can be called a qua...
578 citations
Authors
Showing all 939 results
Name | H-index | Papers | Citations |
---|---|---|---|
P. Johansson | 100 | 584 | 35961 |
Lars Samuelson | 96 | 850 | 36931 |
Nikos Ntoumanis | 74 | 282 | 19459 |
Björn Nilsson | 60 | 232 | 18580 |
Lars Hansson | 60 | 327 | 12065 |
Bengt Fridlund | 57 | 425 | 12222 |
Göran Svensson | 47 | 348 | 7753 |
Lars Bengtsson | 47 | 372 | 8621 |
Chris D. Nugent | 44 | 601 | 9905 |
Sarah Pink | 44 | 213 | 11017 |
Jonas Larsson | 40 | 122 | 7228 |
Michael Bordag | 39 | 213 | 7168 |
Alexey Vinel | 39 | 206 | 4787 |
Josef Bigun | 38 | 202 | 6676 |
Magnus Lindwall | 37 | 101 | 3498 |